Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$1.05−0.04 (-3.67%)

Close on Nov 13, 2026Market cap $12.96MP/E –Yield –

Pluri EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Pluri has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PLUR.

Revenue growth10.0% · median -8.0%

Gross margin52.0% · median 41.3%

Operating margin-2341.1% · median -2020.8%

Net margin-1943.9% · median -1921.7%

Advertisement
300 × 250

See a number that looks wrong?